Advisory Committee on the Medical Uses of Isotopes: Meeting Notice, 67720-67721 [2022-24480]

Download as PDF 67720 Federal Register / Vol. 87, No. 216 / Wednesday, November 9, 2022 / Notices NATIONAL SCIENCE FOUNDATION National Science Foundation Sunshine Act Meetings Sunshine Act Meetings The National Science Board’s (NSB) Committee on Science and Engineering Policy hereby gives notice of the scheduling of a teleconference for the transaction of National Science Board business pursuant to the National Science Foundation Act and the Government in the Sunshine Act. TIME AND DATE: Monday, November 14, 2022, from 12:00 p.m.–12:30 p.m. EST. Friday, November 18, 2022, from 3:30 p.m.–4:00 p.m. EST. PLACE: This meeting will be held by video conference through the National Science Foundation. STATUS: Open. MATTERS TO BE CONSIDERED: The agenda for the November 14 meeting is: Chair’s opening remarks; discussion of the narrative outline for the SEI 2024 Higher Education 2024 thematic report. The agenda for the November 18 meeting is: Chair’s opening remarks; discussion of the narrative outline for the SEI 2024 Labor Force thematic report. CONTACT PERSON FOR MORE INFORMATION: Point of contact for this meeting is: (Chris Blair, cblair@nsf.gov), 703/292– 7000. The link to a You Tube livestream will be available from the meeting notice web page: https://www.nsf.gov/ nsb/meetings/index.jsp. Christopher Blair, Executive Assistant to the National Science Board Office. [FR Doc. 2022–24640 Filed 11–7–22; 4:15 pm] khammond on DSKJM1Z7X2PROD with NOTICES BILLING CODE 7555–01–P FEDERAL REGISTER CITATION OF PREVIOUS ANNOUNCEMENT: This meeting was noticed on October 28. 2022, at 87 FR 65258. PREVIOUSLY ANNOUNCED TIME AND DATE OF THE MEETING: Friday, November 4, 2022, from 2:00–3:00 p.m. EDT. This meeting is CANCELLED. CONTACT PERSON FOR MORE INFORMATION: Point of contact for this meeting is: Chris Blair, cblair@nsf.gov, 703–292– 7000. CHANGES IN THE MEETING: Christopher Blair, Executive Assistant to the National Science Board Office. [FR Doc. 2022–24635 Filed 11–7–22; 4:15 pm] BILLING CODE 7555–01–P NUCLEAR REGULATORY COMMISSION Advisory Committee on the Medical Uses of Isotopes: Meeting Notice Nuclear Regulatory Commission. ACTION: Notice of meeting. AGENCY: The U.S. Nuclear Regulatory Commission (NRC) will convene a meeting of the Advisory Committee on the Medical Uses of Isotopes (ACMUI) on December 5–6, 2022. A sample of agenda items to be discussed during the public session includes: an overview of Y–90 medical events; overview of the review of Lu–177–PSMA for the treatment of adult patients with prostate SUMMARY: cancer; review of pre-rulemaking documents for the rulemaking to establish requirements for Rb–82 generators and emerging medical technologies; and overview of the status of rulemaking for regulations for decommissioning financial assurance for sealed and unsealed radioactive materials. The agenda is subject to change. The current agenda and any updates will be available on the ACMUI’s Meetings and Related Documents web page at https:// www.nrc.gov/reading-rm/doccollections/acmui/meetings/2022.html or by emailing Ms. Gupta Sarma at the contact information below. Purpose: Discuss issues related to 10 CFR part 35, Medical Use of Byproduct Material. Date and Time for Open Sessions: December 5, 2022, from 8:30 a.m. to 4:30 p.m. EST, December 6, 2022, from 10:00 a.m. to 12:00 p.m. EST. Date and Time for Closed Session: December 6, 2022, from 1:30 p.m. to 3:30 p.m. EST. This session will be closed to conduct the ACMUI’s required annual training. Address for Public Meeting: U.S. Nuclear Regulatory Commission, One White Flint North Building, Commissioner’s Hearing Room, 11555 Rockville Pike, Rockville, Maryland 20852. Date Webinar information (Microsoft teams) December 5, 2022 ....... Link: https://teams.microsoft.com/l/meetup-join/19%3ameeting_MGZiN2JhZDctNGMzYS00OTRj LWFiYjktYjNjMDM3Y2RhOGI2%40thread.v2/0?context=%7b%22Tid%22%3a%22e8d01475-c3b5-436a-a0655def4c64f52e%22%2c%22Oid%22%3a%225b3cab2a-da77-46d1-b0df-ca02d21f6361%22%7d. Meeting ID: 248 090 740 397. Passcode: HE2JRc. Call in number (audio only): +1 301–576–2978 (Silver Spring, MD, US). Phone Conference ID: 767 488 798#. Public Participation: Any member of the public who wishes to participate in the meeting in person, via Microsoft Teams, or via phone should contact Ms. Gupta Sarma using the information below. The Meeting will be webcast live from the NRC’s Webcast Portal at https://video.nrc.gov/. Members of the public should also monitor the NRC’s Public Meeting Schedule at https:// www.nrc.gov/pmns/mtg for any meeting updates. VerDate Sep<11>2014 17:09 Nov 08, 2022 Jkt 259001 Contact Information: Ms. Gupta Sarma, email: TXG5@nrc.gov. Conduct of the Meeting The ACMUI Chair, Darlene F. Metter, M.D., will preside over the meeting. Dr. Metter will conduct the meeting in a manner that will facilitate the orderly conduct of business. The following procedures apply to public participation in the meeting: PO 00000 Frm 00052 Fmt 4703 Sfmt 4703 1. Persons who wish to provide a written statement should submit an electronic copy to Ms. Gupta Sarma using the contact information listed above. All submittals must be received by the close of business on November 29, 2022 and must only pertain to the topics on the agenda. 2. Questions and comments from members of the public will be permitted during the meeting, at the discretion of the ACMUI Chair. E:\FR\FM\09NON1.SGM 09NON1 Federal Register / Vol. 87, No. 216 / Wednesday, November 9, 2022 / Notices 3. The draft transcript and meeting summary will be available on ACMUI’s website https://www.nrc.gov/readingrm/doc-collections/acmui/meetings/ 2022.html on or about January 20, 2023. 4. Persons who require special services, such as those for the hearing impaired, should notify Ms. Gupta Sarma of their planned participation. This meeting will be held in accordance with the Atomic Energy Act of 1954, as amended (primarily Section 161a); the Federal Advisory Committee Act (5 U.S.C. App); and the Commission’s regulations in Title 10 of the Code of Federal Regulations, Part 7. Dated at Rockville, Maryland this 4th day of November 2022. For the U.S. Nuclear Regulatory Commission. Russell E. Chazell, Federal Advisory Committee Management Officer. [FR Doc. 2022–24480 Filed 11–8–22; 8:45 am] BILLING CODE 7590–01–P POSTAL REGULATORY COMMISSION [Docket Nos. MC2023–32 and CP2023–31; MC2023–33 and CP2023–32] New Postal Products Postal Regulatory Commission. Notice. AGENCY: ACTION: The Commission is noticing a recent Postal Service filing for the Commission’s consideration concerning a negotiated service agreement. This notice informs the public of the filing, invites public comment, and takes other administrative steps. DATES: Comments are due: November 14, 2022. ADDRESSES: Submit comments electronically via the Commission’s Filing Online system at https:// www.prc.gov. Those who cannot submit comments electronically should contact the person identified in the FOR FURTHER INFORMATION CONTACT section by telephone for advice on filing alternatives. SUMMARY: FOR FURTHER INFORMATION CONTACT: khammond on DSKJM1Z7X2PROD with NOTICES David A. Trissell, General Counsel, at 202–789–6820. SUPPLEMENTARY INFORMATION: Table of Contents I. Introduction II. Docketed Proceeding(s) to negotiated service agreement(s). The request(s) may propose the addition or removal of a negotiated service agreement from the Market Dominant or the Competitive product list, or the modification of an existing product currently appearing on the Market Dominant or the Competitive product list. Section II identifies the docket number(s) associated with each Postal Service request, the title of each Postal Service request, the request’s acceptance date, and the authority cited by the Postal Service for each request. For each request, the Commission appoints an officer of the Commission to represent the interests of the general public in the proceeding, pursuant to 39 U.S.C. 505 (Public Representative). Section II also establishes comment deadline(s) pertaining to each request. The public portions of the Postal Service’s request(s) can be accessed via the Commission’s website (https:// www.prc.gov). Non-public portions of the Postal Service’s request(s), if any, can be accessed through compliance with the requirements of 39 CFR 3011.301.1 The Commission invites comments on whether the Postal Service’s request(s) in the captioned docket(s) are consistent with the policies of title 39. For request(s) that the Postal Service states concern Market Dominant product(s), applicable statutory and regulatory requirements include 39 U.S.C. 3622, 39 U.S.C. 3642, 39 CFR part 3030, and 39 CFR part 3040, subpart B. For request(s) that the Postal Service states concern Competitive product(s), applicable statutory and regulatory requirements include 39 U.S.C. 3632, 39 U.S.C. 3633, 39 U.S.C. 3642, 39 CFR part 3035, and 39 CFR part 3040, subpart B. Comment deadline(s) for each request appear in section II. II. Docketed Proceeding(s) 1. Docket No(s).: MC2023–32 and CP2023–31; Filing Title: USPS Request to Add Priority Mail Express International, Priority Mail International & First-Class Package International Service Contract 10 to Competitive Product List and Notice of Filing Materials Under Seal; Filing Acceptance Date: November 3, 2022; Filing Authority: 39 U.S.C. 3642, 39 CFR 3040.130 through 3040.135, and 39 CFR 3035.105; Public Representative: Kenneth R. Moeller; Comments Due: November 14, 2022. I. Introduction The Commission gives notice that the Postal Service filed request(s) for the Commission to consider matters related VerDate Sep<11>2014 17:09 Nov 08, 2022 Jkt 259001 1 See Docket No. RM2018–3, Order Adopting Final Rules Relating to Non-Public Information, June 27, 2018, Attachment A at 19–22 (Order No. 4679). PO 00000 Frm 00053 Fmt 4703 Sfmt 4703 67721 2. Docket No(s).: MC2023–33 and CP2023–32; Filing Title: USPS Request to Add Priority Mail Express, Priority Mail, First-Class Package Service & Parcel Select Contract 78 to Competitive Product List and Notice of Filing Materials Under Seal; Filing Acceptance Date: November 3, 2022; Filing Authority: 39 U.S.C. 3642, 39 CFR 3040.130 through 3040.135, and 39 CFR 3035.105; Public Representative: Kenneth R. Moeller; Comments Due: November 14, 2022. This Notice will be published in the Federal Register. Erica A. Barker, Secretary. [FR Doc. 2022–24504 Filed 11–8–22; 8:45 am] BILLING CODE 7710–FW–P SECURITIES AND EXCHANGE COMMISSION [Release No. 34–96219; File No. SR–NSCC– 2022–013] Self-Regulatory Organizations; National Securities Clearing Corporation; Notice of Filing of Proposed Rule Change To Amend the Clearing Agency Liquidity Risk Management Framework To Include a New Section Describing the Process by Which FICC Would Designate Uncommitted Resources as Qualifying Liquid Resources and Make Other Changes November 3, 2022. Pursuant to Section 19(b)(1) of the Securities Exchange Act of 1934 (‘‘Act’’) 1 and Rule 19b–4 thereunder,2 notice is hereby given that on October 20, 2022, National Securities Clearing Corporation (‘‘NSCC’’) filed with the Securities and Exchange Commission (‘‘Commission’’) the proposed rule change as described in Items I, II and III below, which Items have been prepared by the clearing agency. The Commission is publishing this notice to solicit comments on the proposed rule change from interested persons. I. Clearing Agency’s Statement of the Terms of Substance of the Proposed Rule Change The proposed rule change consists of amendments to the Clearing Agency Liquidity Risk Management Framework (‘‘Framework’’) of NSCC and its affiliates, The Depository Trust Company (‘‘DTC’’) and Fixed Income Clearing Corporation (‘‘FICC,’’ and together with NSCC and DTC, the 1 15 2 17 U.S.C. 78s(b)(1). CFR 240.19b–4. E:\FR\FM\09NON1.SGM 09NON1

Agencies

[Federal Register Volume 87, Number 216 (Wednesday, November 9, 2022)]
[Notices]
[Pages 67720-67721]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-24480]


=======================================================================
-----------------------------------------------------------------------

NUCLEAR REGULATORY COMMISSION


Advisory Committee on the Medical Uses of Isotopes: Meeting 
Notice

AGENCY: Nuclear Regulatory Commission.

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: The U.S. Nuclear Regulatory Commission (NRC) will convene a 
meeting of the Advisory Committee on the Medical Uses of Isotopes 
(ACMUI) on December 5-6, 2022. A sample of agenda items to be discussed 
during the public session includes: an overview of Y-90 medical events; 
overview of the review of Lu-177-PSMA for the treatment of adult 
patients with prostate cancer; review of pre-rulemaking documents for 
the rulemaking to establish requirements for Rb-82 generators and 
emerging medical technologies; and overview of the status of rulemaking 
for regulations for decommissioning financial assurance for sealed and 
unsealed radioactive materials. The agenda is subject to change. The 
current agenda and any updates will be available on the ACMUI's 
Meetings and Related Documents web page at https://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/2022.html or by emailing Ms. Gupta 
Sarma at the contact information below.
    Purpose: Discuss issues related to 10 CFR part 35, Medical Use of 
Byproduct Material.
    Date and Time for Open Sessions: December 5, 2022, from 8:30 a.m. 
to 4:30 p.m. EST, December 6, 2022, from 10:00 a.m. to 12:00 p.m. EST.
    Date and Time for Closed Session: December 6, 2022, from 1:30 p.m. 
to 3:30 p.m. EST. This session will be closed to conduct the ACMUI's 
required annual training.
    Address for Public Meeting: U.S. Nuclear Regulatory Commission, One 
White Flint North Building, Commissioner's Hearing Room, 11555 
Rockville Pike, Rockville, Maryland 20852.

------------------------------------------------------------------------
                                       Webinar information (Microsoft
               Date                                teams)
------------------------------------------------------------------------
December 5, 2022..................  Link: https://teams.microsoft.com/l/meetup-join/19%3ameeting_MGZiN2JhZDctNGMzYS00OTRjLWFiYjktYjNjMDM3Y2RhOGI2%40thread.v2/0?context=%7b%22Tid%22%3a%22e8d01475-c3b5-436a-a065-5def4c64f52e%22%2c%22Oid%22%3a%225b3cab2a-da77-46d1-b0df-ca02d21f6361%22%7d.
                                    Meeting ID: 248 090 740 397.
                                    Passcode: HE2JRc.
                                    Call in number (audio only): +1 301-
                                     576-2978 (Silver Spring, MD, US).
                                    Phone Conference ID: 767 488 798#.
------------------------------------------------------------------------

    Public Participation: Any member of the public who wishes to 
participate in the meeting in person, via Microsoft Teams, or via phone 
should contact Ms. Gupta Sarma using the information below. The Meeting 
will be webcast live from the NRC's Webcast Portal at https://video.nrc.gov/. Members of the public should also monitor the NRC's 
Public Meeting Schedule at https://www.nrc.gov/pmns/mtg for any meeting 
updates.
    Contact Information: Ms. Gupta Sarma, email: [email protected].

Conduct of the Meeting

    The ACMUI Chair, Darlene F. Metter, M.D., will preside over the 
meeting. Dr. Metter will conduct the meeting in a manner that will 
facilitate the orderly conduct of business. The following procedures 
apply to public participation in the meeting:
    1. Persons who wish to provide a written statement should submit an 
electronic copy to Ms. Gupta Sarma using the contact information listed 
above. All submittals must be received by the close of business on 
November 29, 2022 and must only pertain to the topics on the agenda.
    2. Questions and comments from members of the public will be 
permitted during the meeting, at the discretion of the ACMUI Chair.

[[Page 67721]]

    3. The draft transcript and meeting summary will be available on 
ACMUI's website https://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/2022.html on or about January 20, 2023.
    4. Persons who require special services, such as those for the 
hearing impaired, should notify Ms. Gupta Sarma of their planned 
participation.
    This meeting will be held in accordance with the Atomic Energy Act 
of 1954, as amended (primarily Section 161a); the Federal Advisory 
Committee Act (5 U.S.C. App); and the Commission's regulations in Title 
10 of the Code of Federal Regulations, Part 7.

    Dated at Rockville, Maryland this 4th day of November 2022.

    For the U.S. Nuclear Regulatory Commission.
Russell E. Chazell,
Federal Advisory Committee Management Officer.
[FR Doc. 2022-24480 Filed 11-8-22; 8:45 am]
BILLING CODE 7590-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.